Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0X789 | ISIN: US46333X1081 | Ticker-Symbol: I76
Tradegate
31.10.24
18:48 Uhr
3,740 Euro
-0,140
-3,61 %
1-Jahres-Chart
IRONWOOD PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
IRONWOOD PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,7803,92013:02
3,8203,92001.11.

Aktuelle News zur IRONWOOD PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
30.09.IRONWOOD PHARMACEUTICALS INC - 8-K, Current Report9
30.09.Ironwood Pharmaceuticals' SWOT analysis: apraglutide potential boosts stock outlook15
09.09.Leerink sets Ironwood Pharma at Market Perform rating with consistent target12
02.09.Ironwood Pharmaceuticals, Inc. (IRWD): The Best Multibagger Penny Stock of 2025?11
14.08.Ironwood Pharmaceuticals executive sells over $42k in stock7
09.08.Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates6
08.08.IRONWOOD PHARMACEUTICALS INC - 10-Q, Quarterly Report4
08.08.IRONWOOD PHARMACEUTICALS INC - 8-K, Current Report6
08.08.Ironwood Pharmaceuticals Reports Second Quarter 2024 Results194BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its second quarter 2024 results and recent business performance. "We...
► Artikel lesen
20.06.IRONWOOD PHARMACEUTICALS INC - 8-K, Current Report4
10.05.Earnings call: Ironwood Pharmaceuticals reports robust Q1 growth7
10.05.Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates2
09.05.IRONWOOD PHARMACEUTICALS INC - 10-Q, Quarterly Report2
09.05.IRONWOOD PHARMACEUTICALS INC - 8-K, Current Report1
09.05.Ironwood Pharmaceuticals Reports First Quarter 2024 Results222BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its first quarter 2024 results and recent business performance. "In the...
► Artikel lesen
15.02.Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance377BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its fourth quarter and full year 2023 results and recent business performance. "In...
► Artikel lesen
12.12.23Ironwood Pharmaceuticals, Inc. Announces the Completion of Squeeze-Out Merger With VectivBio424BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. ("Ironwood") (Nasdaq: IRWD), a GI-focused healthcare company, today announced the successful completion of the squeeze-out merger under Swiss...
► Artikel lesen
09.11.23Ironwood Pharmaceuticals Reports Third Quarter 2023 Results215BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its third quarter 2023 results and recent business performance. "We are...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1